Search details
1.
Evolving Concepts in Helicobacter pylori Management.
Gastroenterology
; 166(2): 267-283, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37806461
2.
PNPLA3, obesity and heavy alcohol use in cirrhosis patients may exert a synergistic increase hepatocellular carcinoma risk.
Clin Gastroenterol Hepatol
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38729396
3.
Risk factors for HCC in contemporary cohorts of patients with cirrhosis.
Hepatology
; 77(3): 997-1005, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35229329
4.
Recent Trends in the Incidence of Gastric Cancer in the United States.
J Clin Gastroenterol
; 58(1): 39-45, 2024 01 01.
Article
in English
| MEDLINE | ID: mdl-36413030
5.
Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution.
J Clin Gastroenterol
; 58(5): 432-439, 2024.
Article
in English
| MEDLINE | ID: mdl-37436841
6.
Proton pump inhibitors: rational use and use-reduction. The Windsor Workshop.
Dig Dis
; 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38513623
7.
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
Dig Dis Sci
; 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38700632
8.
Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Semin Liver Dis
; 43(1): 89-99, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36216350
9.
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease.
J Hepatol
; 78(3): 493-500, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36402450
10.
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States.
Clin Gastroenterol Hepatol
; 21(2): 415-423.e4, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35124267
11.
Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas.
Clin Gastroenterol Hepatol
; 21(5): 1314-1322.e5, 2023 05.
Article
in English
| MEDLINE | ID: mdl-35933074
12.
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus.
Clin Gastroenterol Hepatol
; 21(4): 1111-1113.e3, 2023 04.
Article
in English
| MEDLINE | ID: mdl-35276326
13.
Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia.
Clin Gastroenterol Hepatol
; 21(1): 64-71, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35569739
14.
The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population.
Clin Gastroenterol Hepatol
; 21(7): 1771-1780, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36270616
15.
The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting.
Clin Gastroenterol Hepatol
; 21(5): 1252-1260.e5, 2023 05.
Article
in English
| MEDLINE | ID: mdl-35811043
16.
Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis.
Clin Gastroenterol Hepatol
; 21(4): 1023-1030.e39, 2023 04.
Article
in English
| MEDLINE | ID: mdl-35680035
17.
Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett's Esophagus.
Clin Gastroenterol Hepatol
; 21(5): 1198-1204, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36115659
18.
Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference.
Clin Gastroenterol Hepatol
; 21(9): 2183-2192, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37086825
19.
Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis.
Clin Gastroenterol Hepatol
; 21(13): 3296-3304.e3, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37390101
20.
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease.
Hepatology
; 75(6): 1420-1428, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34779535